In vivo biology of mammalian L1 retrotransposition
哺乳动物 L1 逆转录转座的体内生物学
基本信息
- 批准号:10549834
- 负责人:
- 金额:$ 38.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-12 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAgingAllelesAmino Acid MotifsAnimalsAttenuatedAutomobile DrivingBiochemicalBiogenesisBiologicalBiologyBreedingCell LineComplexCultured CellsDNA DamageDefectDiseaseElementsEndosomesEnterobacteria phage P1 Cre recombinaseEventFamilyFrequenciesFutureGenesGenetic PolymorphismGenetic RecombinationGenetic ScreeningGenomeGenomicsGerm CellsGerm LinesHumanInfertilityIntegration Host FactorsKnock-in MouseKnock-outKnockout MiceKnowledgeLeptotene StageMale InfertilityMale SterilityMale SterilizationsMalignant NeoplasmsMammalsMeiosisMeiotic Prophase IModelingMusMutateMutationNuclearPachytene StagePathway interactionsPhenotypePlayProductivityProphaseRegulationRetrotranspositionRibonucleoproteinsRoleSmall RNASortingSpermatocytesTransgenesWild Type MouseWorkYeastsZygonemacell immortalizationgenome integrityhuman malehuman tissuein vivoinsightmalemammalian genomemodel organismmouse geneticsmouse modelmutantnervous system disorderoverexpressionparticlepiRNApromotertissue culturetraffickingtransposon/insertion element
项目摘要
PROJECT SUMMARY
Long Interspersed Nuclear Elements (LINEs) are a class of retrotransposable elements that continually mutate
genomes, including mammalian genomes. The currently active family of LINEs in mammals is called LINE-1
(L1). There are hundreds of thousands of copies of L1 in mammalian genomes, and unchecked expression of
this element in humans and/or model organisms is associated with various abnormal states, such as cancer,
infertility, aging and neurologic disease. We do not know whether L1 plays a causative role in these disorders,
partly because our knowledge of L1 biology in vivo is rudimentary, which has limited our ability to experimentally
manipulate endogenous L1 activity in a specific manner. Although a number of cellular host factors that can alter
L1 retrotransposition have been identified from biochemical pulldowns and genetic screens in immortalized cell
lines, the in vivo biological relevance of these factors in the evolutionarily relevant germ cells is unclear.
Previously our lab discovered that the endosomal sorting complex required for transport (ESCRT) plays a critical
role for productive LINE retrotransposition in both yeast and human tissue culture. This proposal will use mouse
genetics to examine whether ESCRT is used for L1 intracellular trafficking and retrotransposition in the male
germ line, and whether disruption of the ESCRT/L1 interaction can alleviate germ line defects found in a mouse
models of infertility. To this end, we will utilize both wild type mice and mice with known increases in L1
expression in the germline. Mice deleted in the gene for Maelstrom (Mael-/-) have massive overexpression of L1,
arrest in meiotic prophase I, and are male sterile. Maelstrom is involved in the biogenesis of small RNAs in the
germ line, called piRNAs, and similar transposon/infertility defects are seen when related piRNA biogenesis
genes (e.g. Mov10l1) are knocked out in mice. It is currently unknown whether L1 is a driving factor of infertility
in these mice. To reduce L1 activity, we will introduce an ALIX knockout allele (ALIX is a component of the
ESCRT complex). In Aim 1 we will evaluate germ line L1 RNP localization, regulation, and retrotransposition
when the L1/ESCRT interaction is disrupted. In Aim 2 we will determine the contribution of L1 overexpression to
germ cell phenotypes in mice. This project will provide valuable insight into whether ESCRT enables L1 RNP
trafficking in the germ line. The proposed work will also shed light on whether excess L1 retrotransposition is a
driving factor responsible for infertility in piRNA pathway mutants. Because L1 and the piRNA pathway are
conserved in humans, and mutations in piRNA pathway genes have been associated with human infertility, we
expect that this work will form the basis for future study on the relation between transposon regulation and some
cases of human male infertility.
项目摘要
长散布核元件(LINEs)是一类不断突变的逆转录转座元件
基因组,包括哺乳动物基因组。哺乳动物中目前活跃的LINE家族被称为LINE-1
(L1)。在哺乳动物基因组中有数十万个L1拷贝,
人类和/或模式生物体中的这种元素与各种异常状态,例如癌症,
不孕、衰老和神经系统疾病。我们不知道L1是否在这些疾病中起着致病作用,
部分原因是我们对L1生物学的了解还很初级,这限制了我们在实验上研究L1生物学的能力。
以特定方式操纵内源性L1活性。尽管一些细胞宿主因素可以改变
L1反转录转座已经从永生化细胞的生化下拉和遗传筛选中鉴定出来
线,这些因素在进化相关的生殖细胞的体内生物学相关性尚不清楚。
以前我们的实验室发现,运输所需的内体分选复合物(ESCRT)在运输中起着关键作用。
在酵母和人类组织培养中生产性LINE反转录转座的作用。这个建议将使用鼠标
遗传学,以检查ESCRT是否用于男性中的L1细胞内运输和逆转录转座
以及ESCRT/L1相互作用的破坏是否可以减轻小鼠中发现的生殖系缺陷
不孕症的模型。为此,我们将利用野生型小鼠和已知L1增加的小鼠
在生殖细胞系中表达。缺失Maelstrom基因(Mael-/-)的小鼠具有L1的大量过表达,
在减数分裂前期I停滞,并且是雄性不育的。Maelstrom参与小RNA的生物合成,
生殖系,称为piRNA,当相关的皮尔纳生物合成时,
基因(例如Mov 10 l1)在小鼠中被敲除。目前尚不清楚L1是否是不孕症的驱动因素
在这些老鼠身上。为了降低L1活性,我们将引入阿利克斯敲除等位基因(阿利克斯是L1基因的一个组成部分)。
ESCRT复合物)。在目标1中,我们将评估生殖系L1 RNP的定位、调控和反转录转座
当L1/ESCRT相互作用被破坏时。在目标2中,我们将确定L1过表达对
小鼠生殖细胞表型。该项目将为ESCRT是否能够实现L1 RNP提供有价值的见解
贩卖生殖细胞拟议的工作也将阐明过量的L1逆转录是否是一个潜在的问题。
导致皮尔纳途径突变体不育的驱动因子。因为L1和皮尔纳通路是
在人类中是保守的,皮尔纳途径基因的突变与人类不育有关,我们
我希望这项工作将成为未来研究转座子调控与某些生物学特性之间关系的基础。
人类男性不育的病例。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey S Han其他文献
Jeffrey S Han的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey S Han', 18)}}的其他基金
In vivo biology of mammalian L1 retrotransposition
哺乳动物 L1 逆转录转座的体内生物学
- 批准号:
10367362 - 财政年份:2022
- 资助金额:
$ 38.34万 - 项目类别:
In vivo biology of mammalian L1 retrotransposition - supplement
哺乳动物 L1 逆转录转座的体内生物学 - 补充
- 批准号:
10578990 - 财政年份:2022
- 资助金额:
$ 38.34万 - 项目类别:
Using budding yeast to study LINE (L1) retrotransposition
使用芽殖酵母研究 LINE (L1) 逆转录转座
- 批准号:
8499365 - 财政年份:2010
- 资助金额:
$ 38.34万 - 项目类别:
Using budding yeast to study LINE (L1) retrotransposition
使用芽殖酵母研究 LINE (L1) 逆转录转座
- 批准号:
8101968 - 财政年份:2010
- 资助金额:
$ 38.34万 - 项目类别:
Using budding yeast to study LINE (L1) retrotransposition
使用芽殖酵母研究 LINE (L1) 逆转录转座
- 批准号:
8294975 - 财政年份:2010
- 资助金额:
$ 38.34万 - 项目类别:
Using budding yeast to study LINE (L1) retrotransposition
使用芽殖酵母研究 LINE (L1) 逆转录转座
- 批准号:
7985631 - 财政年份:2010
- 资助金额:
$ 38.34万 - 项目类别:
Using budding yeast to study LINE (L1) retrotransposition
使用芽殖酵母研究 LINE (L1) 逆转录转座
- 批准号:
8775361 - 财政年份:2010
- 资助金额:
$ 38.34万 - 项目类别:
Using budding yeast to study LINE (L1) retrotransposition
使用芽殖酵母研究 LINE (L1) 逆转录转座
- 批准号:
8686000 - 财政年份:2010
- 资助金额:
$ 38.34万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 38.34万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 38.34万 - 项目类别:
Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 38.34万 - 项目类别:
Collaborative R&D
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 38.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 38.34万 - 项目类别:
Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 38.34万 - 项目类别:
Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 38.34万 - 项目类别:
Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 38.34万 - 项目类别:
Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
- 批准号:
23K20355 - 财政年份:2024
- 资助金额:
$ 38.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
- 批准号:
23K24782 - 财政年份:2024
- 资助金额:
$ 38.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)